| “Suicide CARE”(standardized suicide prevention program for gatekeeper intervention in Korea): an update SC Park, KS Na, SJ Kwon, M Kim, HJ Kim, M Baik, J Seol, EJ An, SM Lee, ... Psychiatry investigation 17 (9), 911, 2020 | 21 | 2020 |
| [P2–119]: THE ASSOCIATION BETWEEN CACNA1C GENE POLYMORPHISM AND LATE‐ONSET ALZHEIMER's DISEASE IN THE KOREAN POPULATION JY Song, WS Kang, JW Kim, JW Paik Alzheimer's & Dementia 13 (7S_Part_13), P652-P653, 2017 | | 2017 |
| 1.42 PSYCHIATRIC HOSPITALIZATION AND POSTDISCHARGE SUICIDE AMONG CHILDREN AND ADOLESCENTS IN KOREA 2008-2013 M Hong, SM Lee, KH Kim, JW Paik Journal of the American Academy of Child & Adolescent Psychiatry 10 (55), S113, 2016 | | 2016 |
| 27th Annual Meeting of the Swiss Society of Biological Psychiatry R Göder, G Fritzer, D Hinze-Selch, C Huchzermeier, JM Koch, ... Neuropsychobiology 55 (1), 52-72, 2007 | | 2007 |
| 韓国の自殺対策 (Suicide and Countermeasures in Korea) の現状と課題 (第 43 回日本自殺予防学会総会 「支え合いとつながりで 皆で紡ぐ自殺対策」)--(シンポジウム 自殺予防と国際協働活動) JW Paik, HS Park, YJ Park 自殺予防と危機介入 40 (2), 53-59, 2020 | | 2020 |
| A comparison of disease burden and the government budget for mental health in Korea DS Go, YE Kim, JW Paik, S Roh, SJ Yoon Journal of Mental Health 31 (4), 471-478, 2022 | 15 | 2022 |
| A Consideration for the Growth and Development of the Korean Neuropsychiatric Association HY Jung, KJ Lee, HK Lee, JW Paik, KS Na, WS Choi Journal of Korean Neuropsychiatric Association 53 (6), 335-346, 2014 | | 2014 |
| A meta-analysis comparing open-label versus placebo-controlled clinical trials for aripiprazole augmentation in the treatment of major depressive disorder: lessons and promises CU Pae, HJ Seo, BC Lee, JH Seok, HJ Jeon, JW Paik, KP Kwak, BJ Ham, ... Psychiatry Investigation 11 (4), 371, 2014 | 12 | 2014 |
| A research using PHQ-15 on the somatic symptoms of the first visiting patients with depressive disorder at a university hospital JJ Lee, JW Paik, KH Kim, JY Song Journal of Korean Geriatric Psychiatry, 44-51, 2012 | 3 | 2012 |
| A review of the admission system for mental disorders in South Korea DS Go, KC Shin, JW Paik, KA Kim, SJ Yoon International journal of environmental research and public health 17 (24), 9159, 2020 | 14 | 2020 |
| A social psychiatric approach to suicide prevention SW Kim, M Jhon, M Kim, JW Paik, JM Kim, JS Yoon Journal of the Korean Medical Association 62 (2), 93-101, 2019 | 17 | 2019 |
| A study on awareness of depression and needs of a depression support program in the university WJ Kim, SM Kim, EK Kim, KH Kim, JY Song, JW Paik Anxiety and mood 6 (1), 55-64, 2010 | 6 | 2010 |
| A Study on the Long and Mid-term Policy for Korean Neuropsychiatric Association JW Paik, HK Lee, SY Lee, KS Na, KJ Lee, WS Choi, HY Jung Journal of Korean Neuropsychiatric Association 54 (1), 11-15, 2015 | | 2015 |
| Adherence to antidepressant treatment in Korea; an analysis of national insurance data J Paik, K Kim, S Lee, W Lim, N Kim INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE 13, 40-40, 2009 | | 2009 |
| Alexithymia and low cooperativeness are associated with suicide attempts in male military personnel with adjustment disorder: A case–control study KS Na, SJ Oh, HY Jung, SI Lee, YK Kim, C Han, YH Ko, JW Paik, SG Kim Psychiatry research 205 (3), 220-226, 2013 | 37 | 2013 |
| Allelic Variants Interaction of CLOCK Gene and G‐Protein β3 Subunit Gene with Diurnal Preference HJ Lee, JW Paik, SG Kang, SW Lim, L Kim Chronobiology International 24 (4), 589-597, 2007 | 40 | 2007 |
| Alterations in functional brain networks in depressed patients with a suicide attempt history JY Jung, S Choi, KM Han, A Kim, W Kang, JW Paik, HW Lee, BJ Ham Neuropsychopharmacology 45 (6), 964-974, 2020 | 35 | 2020 |
| An 8-week randomized, double-blind trial comparing efficacy, safety, and tolerability of 3 vilazodone dose-initiation strategies following switch from SSRIs and SNRIs in major … S Rele, R Millet, S Kim, JW Paik, S Kim, PS Masand, AA Patkar The primary care companion for CNS disorders 17 (4), 27002, 2015 | 10 | 2015 |
| An 8-Week Randomized, Double-Blind Trial Comparing Efficacy, Safety, and Tolerability of 3 Vilazodone Dose-Initiation Strategies Following Switch From SSRIs and SNRIs in Major … MHA Shilpa Rele, R Millet, S Kim, JW Paik, S Kim, PS Masand, AA Patkar | | 2015 |
| An open-label, rater-blinded, 8-week trial of bupropion hydrochloride extended-release in patients with major depressive disorder with atypical features HJ Seo, BC Lee, JH Seok, HJ Jeon, JW Paik, W Kim, KP Kwak, C Han, ... Pharmacopsychiatry 46 (06), 221-226, 2013 | 12 | 2013 |
Changsu HanProfessor of Psychiatry, Korea University College of Medicine, Korea Univ Guro Hospital在 korea.ac.kr 的电子邮件经过验证
